• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 22nd December 2016

OHE at HESG Winter 2017: Meet the Team

The HESG Winter 2017 Conference is to be held in Birmingham from 4th to 6th January 2017. Several members of the OHE team will be attending and contributing to the conference. This post contains a summary of their activity. The…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The HESG Winter 2017 Conference is to be held in Birmingham from 4th to 6th January 2017. Several members of the OHE team will be attending and contributing to the conference. This post contains a summary of their activity.

The Health Economists’ Study Group (HESG) Winter 2017 Conference is to be hosted by the Health Economics Unit at the University of Birmingham, from Wednesday 4th to Friday 6th January 2017. Several members of the OHE team will be attending and contributing to the conference. We would welcome the opportunity to meet with you to discuss our research; individual contact details can be found through our Meet the Team webpage.

OHE Research being presented:

Multiple rewards: paying physicians (at least) twice for the same activity

Wednesday 4th January: 15:30 – 16:25, Session A (101)

Author: Yan Feng; Chair: Marissa Collins; Discussant: Mark Monahan

The UK Quality and Outcomes Framework (QOF) rewards general practices for achieving quality indicators for management of chronic conditions. Some indicators are multi-rewarded. For example, there are indicators for controlling blood pressure for patients with diabetes and for patients with chronic heart disease (CHD). Thus if a patient has both conditions the practice is rewarded twice for controlling the patient’s blood pressure. 

We compare general practice performance on multi-rewarded indicators with that on singly rewarded indicators.

We find that there is higher reported achievement, lower exception reporting, and higher quality for multi-rewarded indicators than for singly rewarded indicators. We also find that reported achievement and quality is reduced when activity ceases to be multi-rewarded.

New methods for analysing the distribution of EQ-5D observations

Thursday 5th January: 16:20 – 17:15, Session B (102)

Author: Bernarda Zamora; Chair: Jeff Round; Discussant: Nils Gutacker

This paper proposes and tests methods (Health State Density Index, Health State Density Curve and estimated Power Law functions) for characterising and summarising the distribution of self-reported health states within patient and population samples.

Using both these new methods and existing methods from information theory (e.g. Shannon’s Index), we compare the distribution of health profiles across three data sets; for the EQ-5D-5L, Cambridgeshire Community Services NHS’s electronic patient records, and for the EQ-5D-3L data from the Health Survey for England 2014 and the NHS PROMs programme.

In each case, we report the properties of each method and assess their respective merits as measures of diversity and concentration of data. We would like to discuss at this meeting the implications for the collection and interpretation of Patient Reported Outcome data in health economics applications.

OHE discussing other’s research and chairing sessions:

  • Plenary session: Short to Medium-Term Priorities for the NHS

Wednesday 4th January: 18:30-19:30, (101 and 102)

Speakers and Discussants: Judith Smith, Andrew Street, Matt Sutton and Paula Lorgelly

  • Own health valuation: are we asking the right question?

Thursday 5th January: 11:35-12:30, Session E (108)

Author: John Brazier; Chair: Bernarda Zamora; Discussant: Chris Sampson

  • Is the EQ-5D a good fit for people at risk of developing psychosis?

Thursday 5th January: 13:45-14:40, Session B (102)

Author: Elizabeth Camacho; Chair: Chris Sampson; Discussant: Yan Feng

  • The effect of hospital ownership on quality of care for nonemergency patients

Friday 6th January: 09:00-09:55, Session A (101)

Author: Giuseppe Moscelli; Chair: (Not stated); Discussant: Bernarda Zamora

  • EQ-5D and PROMs
  • Events

Related News

MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
  • News
  • January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Read more
  • News
  • September 2019

OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level

Read more
  • News
  • August 2019

OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!